Arena Pharmaceuticals, Inc.;Bozicevic, Field & Francis LLP

EAST PALO ALTO, CA US

1. 20110038850 G Protein-Coupled Receptor and Modulators Thereof For The Treatment of Gaba-Related Neurological Disorders Including Sleep-Related Disorders 02-17-2011
2. 20100331238 Human G protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to MCP-1 expression 12-30-2010
3. 20100317046 Non-Endogenous, Constitutively Activated Versions of Human G Protein Coupled Receptor: FSHR 12-16-2010
4. 20100093604 Gpr43 and modulators thereof for the treatment of metabolic-related disorders 04-15-2010
5. 20100056442 USE OF GPR101 RECEPTOR IN METHODS TO IDENTIFY MODULATORS OF HYPOTHALAMIC PROOPIOMELANOCORTIN (POMC)-DERIVED BIOLOGICALLY ACTIVE PEPTIDE SECRETION USEFUL IN THE TREATMENT OF POMC-DERIVED BIOLOGICALLY 03-04-2010
6. 20100047846 ENDOGENOUS AND NON-ENDOGENOUS VERSIONS OF HUMAN G PROTEIN-COUPLED RECEPTORS 02-25-2010
7. 20090317332 HUMAN G PROTEIN-COUPLED RECEPTOR AND MODULATORS THEREOF FOR THE TREATMENT OF OBESITY AND CONDITIONS RELATED THERETO 12-24-2009
8. 20090313708 GPR22 AND METHODS RELATING THERETO - Methods for generating an expression-enhanced GPR22 nucleic acid as well as substituted GPR22 nucleic acids 12-17-2009
9. 20090280487 METHODS FOR PRODUCING OLFACTORY GPCRS - The subject invention provides a method for producing an olfactory GPCR in a cell 11-12-2009